[go: up one dir, main page]

Leese et al., 1958 - Google Patents

827. Potential anti-purines. Part II. The synthesis of 6-and 9-substituted purines and 8-azapurines

Leese et al., 1958

Document ID
17884301682428130309
Author
Leese C
Timmis G
Publication year
Publication venue
Journal of the Chemical Society (Resumed)

External Links

Snippet

HO CHl* OH purines respectively in high yield, there being no opportunity for the formation of isomers. The syntheses of 6-cycZohexylaminopurine and 6-amino-9-cycZohexylpurine, 4 from 6-chloropurine and cyclohexylamine and from 6-chloro-9-cyclohexylpurine and …
Continue reading at pubs.rsc.org (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulfur or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulfur or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulfur or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulfur or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulfur or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulfur or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulfur or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulfur or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in positions 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulfur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir

Similar Documents

Publication Publication Date Title
Bendich et al. The synthesis and properties of 6-chloropurine and purine1
DE69832715T2 (en) CYCLINE-DEPENDENT KINASE INHIBITING PURE DERIVATIVES
Leonard et al. Reaction of diethyl pyrocarbonate with nucleic acid components. Adenosine
SU1364238A3 (en) Method of obtaining derivatives of pyrimido /4,5-d/quinoline or their optically active isomers or their pharmaceutically acceptable additive salts of acid
US5866702A (en) Purine inhibitors of cyclin dependent kinase 2
EP1268480B1 (en) 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
Elion et al. Studies on condensed pyrimidine systems. XIII. Some amino-substituted derivatives of guanine and 6-thioguanine
FI67847B (en) FREQUENCY REQUIREMENT FOR THERAPEUTIC THERAPY 9-HYDROXIAL CHARGER
NZ233021A (en) Substituted xanthine derivatives and pharmaceutical compositions.
Davies et al. Halogenated pyrrolopyrimidine analogues of adenosine from marine organisms: pharmacological activities and potent inhibition of adenosine kinase
Elion et al. Studies on Condensed Pyrimidine Systems. XVI. Purines and Thiazolo [5, 4-d] pyrimidines from 4-Amino-5-formamido-6-mercaptopyrimidines
AU2969300A (en) Purine inhibitors of cyclin dependent kinase 2 and IkappaBalpha
Jones et al. Potential Purine Antagonists. XXIV. The Preparation and Reactions of Some 8-Diazopurines1
Hecht et al. Cytokinins: synthesis and growth-promoting activity of 2-substituted compounds in the N6-isopentenyladenine and zeatin series
JPS62120386A (en) Manufacture of pteridine derivative
US3314938A (en) Method of preparing 2, 6-dichloropurine and 2, 6-dichloropurine ribofuranosyl
Leese et al. 827. Potential anti-purines. Part II. The synthesis of 6-and 9-substituted purines and 8-azapurines
Davoll 318. The synthesis of the v-triazolo [d] pyrimidine analogues of adenosine, inosine, guanosine, and xanthosine, and a new synthesis of guanosine
Andrews et al. 523. Experiments on the synthesis of purine nucleosides. Part XXVI. 9-D-Glucopyranosidoisoguanine
HU206354B (en) Process for producing selective adenozine receptors and pharmaceutical compositions containing them as active components
Davoll et al. 976. The synthesis of 9-glycitylpurines, 3-glycityl-[1, 2, 3]-triazolo [d]-pyrimidines, 8-glycitylpteridines, and 10-glycitylbenzo [g] pteridines, including riboflavin and riboflavin 2-imine
EP0197390B1 (en) Preparation of n-acetyl serotonine and melatonine
Daly et al. Imidazodiazepinediones: a new class of adenosine receptor antagonists
IT9047999A1 (en) XANTHINIC DERIVATIVES 1-7 SUBSTITUTED FOR ANTIASMATIC ACTIVITY, THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS, THEIR PHARMACEUTICAL COMPOSITIONS AND PROCEDURE FOR THEIR PREPARATION.
Baker et al. Puromycin. Synthetic studies. IV. Glucosyl derivatives of 6-dimethylaminopurine